Holding(s) in Company

RNS Number : 1517Q
Advanced Medical Solutions Grp PLC
03 April 2009
 




For filings with the FSA include the annex

For filings with issuer exclude the annex 


TR-1: Notifications of Major Interests in Shares


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ADVANCED MEDICAL SOL



2. Reason for notification (yes/no)


An acquisition or disposal of voting rights


X


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 



An event changing the breakdown of voting rights



Other (please specify):______________



3. Full name of person(s) subject to notification obligation:

AXA S.A.


4. Full name of shareholder(s) (if different from 3):



5. Date of transaction (and date on which the threshold is crossed or reached if different):


02/04/2009


6. Date on which issuer notified:


03/04/2009


7. Threshold(s) that is/are crossed or reached:


13%



8: Notified Details

A: Voting rights attached to shares


Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights


Direct


Indirect


Direct


Indirect

0453659

19,046,307

19,046,307


400,000

400,000

18,613,307

0.28

12.98




B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights









Total (A+B)


Number of voting rights

Percentage of voting rights


19,013,307


13.26%




9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:


Name of the Company/Fund
Number of Shares
% of Issued Share Capital
AXA Framlington - Indirect
18,113,307.00
12.83149
AXA France - Indirect
500,000.00
0.34868
AXA M UK - Direct
400,000.00
0.27894
 
 
 
Total Direct
400,000
0.27894
Total Indirect
18,613,307
12.98017
TOTAL
19,013,307
13.25911


Proxy Voting:


10. Name of proxy holder:



11. Number of voting rights proxy holder will cease to hold:



12. Date on which proxy holder will cease to hold voting rights:




13. Additional information:



14 Contact name:



15. Contact telephone number:




For notes on how to complete form TR-1 please see the FSA website. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOANRKORSRAR
UK 100

Latest directors dealings